P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US). (23rd June 2022) - Locke, F.; Hu, Z.-H.; Gerson, J.; Frank, M. J.; Budde, L. E.; Wang, M.; Logan, B.; Kloos, I.; Siddiqi, R.; Shah, J.; Xu, H.; Pasquini, M.